1. Development of Coumarin-Thiosemicarbazone Hybrids as Aldose Reductase Inhibitors: Biological Assays, Molecular docking, Simulation studies and ADME Evaluation
   Aqeel Imran et al, 2021, Bioorganic Chemistry CrossRef
2. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
   Christian Bailly, 2022, European Journal of Pharmacology CrossRef